MedTrace Logo

Movement Disorders Caused by Antipsychotic Drugs in Older Patients

NCT00255879 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2013-06-06

No results posted yet for this study

Summary

This study will assess the risk of experiencing tardive dyskinesia and other movement disturbances associated with three atypical antipsychotic drugs among middle-aged and elderly psychiatric patients.

Conditions

  • Dyskinesia, Drug-Induced

Interventions

DRUG

Quetiapine

DRUG

Risperidone

DRUG

Olanzapine

Sponsors & Collaborators

Principal Investigators

  • Dilip V. Jeste, MD · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-01-31
Primary Completion
2004-08-31
Completion
2004-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00255879 on ClinicalTrials.gov